tiprankstipranks
Sunshine Biopharma (SBFM)
NASDAQ:SBFM
US Market
Holding SBFM?
Track your performance easily

Sunshine Biopharma (SBFM) Stock Forecast & Price Target

341 Followers
See the Price Targets and Ratings of:

SBFM Analyst Ratings

Currently, no data available
Based on 0 analysts giving stock ratings to
Sunshine
Biopharma
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

SBFM Stock 12 Month Forecast

There Are No Analyst Ratings for SBFM In The Last 3 Months.
Highest Price TargetAverage Price TargetLowest Price Target
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

SBFM Financial Forecast

SBFM Earnings Forecast

Next quarter’s earnings estimate for SBFM is $256.00 with a range of $256.00 to $256.00. The previous quarter’s EPS was -$0.94. SBFM beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.76% of the time in the same period. In the last calendar year SBFM has Outperformed its overall industry.
Next quarter’s earnings estimate for SBFM is $256.00 with a range of $256.00 to $256.00. The previous quarter’s EPS was -$0.94. SBFM beat its EPS estimate 66.67% of the time in the past 12 months, while its overall industry beat the EPS estimate 56.76% of the time in the same period. In the last calendar year SBFM has Outperformed its overall industry.

SBFM Sales Forecast

Next quarter’s sales forecast for SBFM is $15.50M with a range of $15.50M to $15.50M. The previous quarter’s sales results were $8.44M. SBFM beat its sales estimates 66.67% of the time in past 12 months, while its overall industry beat sales estimates 46.78% of the time in the same period. In the last calendar year SBFM has Outperformed its overall industry.
Next quarter’s sales forecast for SBFM is $15.50M with a range of $15.50M to $15.50M. The previous quarter’s sales results were $8.44M. SBFM beat its sales estimates 66.67% of the time in past 12 months, while its overall industry beat sales estimates 46.78% of the time in the same period. In the last calendar year SBFM has Outperformed its overall industry.

SBFM Analyst Recommendation Trends

Rating
Aug 23
Strong Buy
0
Buy
1
Hold
0
Sell
0
Strong Sell
0
total
1
In the current month, SBFM has received 1 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. SBFM average Analyst price target in the past 3 months is .
Each month's total comprises the sum of three months' worth of ratings.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

SBFM Stock Forecast FAQ

What is SBFM’s average 12-month price target, according to analysts?
Currently, no data Available
What is SBFM’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for SBFM, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
    How can I follow the stock ratings of top Wall Street analysts?
    Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
      Is SBFM a Buy, Sell or Hold?
      Currently, no data Available
      What is Sunshine Biopharma’s price target?
      Currently, no data Available
      What do analysts say about Sunshine Biopharma?
      Not enough analysts have published a price target to provide an average price target.
      How can I buy shares of SBFM?
      Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.
        What am I Missing?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis